Servando Juárez-Ocaña
Mexican Social Security Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Servando Juárez-Ocaña.
BMC Cancer | 2007
Arturo Fajardo-Gutiérrez; Servando Juárez-Ocaña; Guadalupe González-Miranda; Virginia Palma-Padilla; Rogelio Carreón-Cruz; Manuel Carlos Ortega-Alvarez; Juan Manuel Mejía-Aranguré
BackgroundIn 1996, Mexico started to register cases of childhood cancer. Here, we describe the incidence of cancer in children, residing in ten Mexican jurisdictions, who were treated by the Instituto Mexicano del Seguro Social (IMSS).MethodsNew cases of childhood cancer, which were registered prospectively in nine principal Medical Centers of IMSS during the periods 1998–2000 (five jurisdictions) and 1996–2002 (five jurisdictions), were analyzed. Personnel were specifically trained to register, capture, and encode information. For each of these jurisdictions, the frequency, average annual age-standardized incidence (AAS) and average annual incidence per period by sex and, age, were calculated (rates per 1,000,000 children/years).ResultsIn total 2,615 new cases of cancer were registered, with the male/female ratio generally >1, but in some tumors there were more cases in females (retinoblastoma, germ cells tumors). The principal groups of neoplasms in seven jurisdictions were leukemias, central nervous system tumors (CNS tumors), and lymphomas, and the combined frequency for these three groups was 62.6 to 77.2%. Most frequently found (five jurisdictions) was the North American-European pattern (leukemias-CNS tumors-lymphomas). Eight jurisdictions had AAS within the range reported in the world literature. The highest incidence was found for children underless than five year of age. In eight jurisdictions, leukemia had high incidence (>50). The AAS of lymphomas was between 1.9 to 28.6. Chiapas and Guerrero had the highest AAS of CNS tumors (31.9 and 30.3, respectively). The frequency and incidence of neuroblastoma was low. Chiapas had the highest incidence of retinoblastoma (21.8). Germ-cell tumors had high incidence.ConclusionThe North American-European pattern of cancers was the principal one found; the overall incidence was within the range reported worldwide. In general but particularly in two jurisdictions (Yucatán and Chiapas), it will be necessary to carry out studies concerning the causes of cancer in children. Due to the little that is known about the incidence of cancer in Mexican children, it will be necessary to develop a national program to establish a cancer registry for the whole of the country.
BMC Cancer | 2004
Servando Juárez-Ocaña; Guadalupe González-Miranda; Juan Manuel Mejía-Aranguré; Mario Enrique Rendón-Macías; María del Carmen Martínez-García; Arturo Fajardo-Gutiérrez
BackgroundThe objective of this article is to present the frequency of cancer in Mexican children who were treated in the hospitals of the Instituto Mexicano del Seguro Social in Mexico City (IMSS-MC) in the period 1996–2001.MethodsThe Registry of Cancer in Children, started in 1996 in the IMSS-MC, is an on-going, prospective register. The data from 1996 through 2001 were analyzed and the different types of cancer were grouped according to the International Classification for Cancer in Children (ICCC). From this analysis, the general and specific frequencies by age and by sex were obtained for the different groups of neoplasms. Also, the frequency of the stage of the disease that had been diagnosed in cases of children with solid tumors was obtained.ResultsA total of 1,702 new cases of children with cancer were registered, with the male/female ratio at 1.1/1. Leukemias had the highest frequency with 784 cases (46.1%) and, of these, acute lymphoblastic leukemias were the most prevalent with 614 cases (78.3%). Thereafter, in descending order of frequency, were tumors of the central nervous system (CNST) with 197 cases (11.6%), lymphomas with 194 cases (11.4%), germinal cell tumors with 110 cases (6.5%), and bone tumors with 97 cases (5.7%). The highest frequency of cancer was found in the group of one to four year-olds that had 627 cases (36.8%). In all the age groups, leukemias were the most frequent. In the present work, the frequency of Hodgkins disease (~4%) was found to be lower than that (~10%) in previous studies and the frequency of tumors of the sympathetic nervous system was low (2.3%). Of those cases of solid tumors for which the stage of the disease had been determined, 66.9% were diagnosed as being Stage III or IV.ConclusionsThe principal cancers in the children treated in the IMSS-MC were leukemias, CNST, and lymphomas, consistent with those reported by developed countries. A 2.5-fold reduction in the frequency of Hodgkins disease was found. Of the children, the stage of whose disease had been determined, two thirds were diagnosed as having advanced stages of the disease.
Journal of Pediatric Hematology Oncology | 2008
Roberto Bernáldez-Ríos; Manuel Carlos Ortega-Alvarez; María Luisa Pérez-Saldivar; Norma E. Alatoma-Medina; Maria de los Angeles del Campo-Martinez; María del Carmen Rodríguez-Zepeda; Ines Montero-Ponce; Sergio Franco-Ornelas; Gabriela Jazmín Fernández-Castillo; Nora Nancy Núñez-Villegas; Miguel A. Taboada-Flores; Janet Flores-Lujano; Muriel E. Argüelles-Sanchez; Servando Juárez-Ocaña; Arturo Fajardo-Gutiérrez; Juan Manuel Mejía-Aranguré
The objective of this population-based survey was to assess the peak age of incidence of B-cell precursor acute lymphoblastic leukemia (ALL) in children in Mexico City (MC). All patients were classified according to their immunophenotype, and only B-cell precursor and T-lineage were analyzed. Rates of incidence were calculated ×106 children. Of the 364 children from MC who were included in this study, immunophenotyping had been performed for 81.6%. The frequency of B-cell precursor ALL was 76.1%, whereas T lineage ALL showed a frequency of 23.6%. Peak age for ALL was 2 to 3 years of age. B-cell precursor ALL was the major contributor to peak age; T lineage ALL showed a peak among 1 and 3 years of age. We conclude that the age peak for children with ALL in MC is within the ranges reported for developed countries and that B-cell precursor ALL is the main contributor to these peak.
BMC Cancer | 2009
Servando Juárez-Ocaña; Virginia Palma-Padilla; Guadalupe González-Miranda; Alicia Georgina Siordia-Reyes; Enrique López-Aguilar; Martha Aguilar-Martínez; Juan Manuel Mejía-Aranguré; Rogelio Carreón-Cruz; Mario Enrique Rendón-Macías; Arturo Fajardo-Gutiérrez
BackgroundNeuroblastoma (NB) is the principal tumor of the sympathetic nervous system in children under one year of age. The incidence in developed countries is greater than that in developing countries. The aim of this article is to present the epidemiological and some clinical characteristics of Mexican children with NB.MethodsA population-based, prolective study, with data obtained from the Childhood Cancer Registry of the Instituto Mexicano de Seguro Social. Statistical analysis: The simple frequencies of the variables of the study and the annual average incidence (per 1,000,000 children/years) by age and sex were obtained. The trend was evaluated by calculating the annual percentage of change. The curves of Kaplan-Meyer were employed for the survival rate and the log-rank test was used to compare the curves.ResultsOf a total of 2,758 children with cancer registered during the period from 1996–2005, 72 (2.6%) were identified as having Group IV, defined according to the International Classification of Childhood Cancer. The incidence for NB was 3.8 per 1,000,000 children/year; NB was highest in the group of children under one year of age, followed by the group of children between the ages 1–4 years (18.5 and 5.4 per 1,000,000 children/years, respectively). The male/female ratio was 1.1 and there was no trend toward an increase. The time of diagnosis was 26 days (median), but varied according to the stage at diagnosis. Stages III and IV were presented in 88% of the cases. There was no association between the stage, the age at time of diagnosis, or the histological pattern. The overall five-year survival rate was 64%; the patients with stage I, II, III, or IVs did not die; and the five-year survival rate of cases in Stage IV was 40%.ConclusionIt is possible that the low incidence of neuroblastoma in Mexican children is due to the difficulty in diagnosing the cases with the best prognosis, some of which could have had spontaneous regression. There was no trend to an increase; the majority of the cases were diagnosed in the advanced stages; and the overall five-years survival rate was similar to that for developed countries.
European Journal of Cancer Prevention | 2005
Mario Enrique Rendón-Macías; Juan Manuel Mejía-Aranguré; Servando Juárez-Ocaña; Arturo Fajardo-Gutiérrez
In this work, the epidemiology of cancer in children under one year of age in Mexico City is described. A survey (observational, descriptive and prolective study) from 1 January 1996 to 31 December 1999 was conducted at two paediatric hospitals of the Instituto Mexicano de Seguro Social in Mexico City (IMSS-MC). To calculate both the general and the by sex incidence (rates are given per 106) all new cases recorded for children under one year of age (numerator) and Mexico City population served by the IMSS (denominator) were used. When the total of 34 cases that fulfilled the requirements was analysed, an incidence of 194.5 was obtained. Leukaemia occupied first place with a rate of 68.6 and hepatic and germinal cells tumours occupied second place with an incidence of 28.6, whereas peripheral nervous system tumours (neuroblastoma) showed a very low rate (11.4). Overall, the male/female ratio for tumours was 1.4:1, with the ratio varying with different types of tumours. Cancer incidence in this population was shown to be close to that in developed countries, but differed in the distribution of the type of tumour: leukaemia had a very high incidence and that for neuroblastoma was very low.
Salud Publica De Mexico | 2002
Juan Manuel Mejía-Aranguré; Olbeth Beutelspacher-Vázquez; Servando Juárez-Ocaña; José Vázquez-Langle; María del Carmen Martínez-García; Arturo Fajardo-Gutiérrez
Objective. To evaluate the incidence trends of hepatic tumors among children living in Mexico City. Material and Methods. A cross-sectional hospital survey was conducted to yield two databases. The first database contains the registry of all the cases of hepatic tumors occurring during the period 1982-1991, in public hospitals of Mexico City. The second database contains all hepatic tumor cases found between 1996 and 1999 in Hospital de Pediatria del Centro Medico Nacional “Siglo XXI” and in Hospital General del Centro Medico La Raza, both hospitals pertaining to Instituto Mexicano del Seguro Social (Mexican Institute of Social Security). The average annual incidence rates (AAIR) were calculated for each type of hepatic tumor. The rates were standardized with the direct method, using as standard the world population under 15 years of age. The trends were evaluated with the annual incidence rates and the average rate of change assuming a Poisson distribution. Results. The AAIR for hepatoblastoma during the period 1982-1991 was three times higher for men than for women, with a value of 0.6 x10 6 . The group of 1-4 years of age was the most affected. For hepatocarcinomas the AAIR was twofold for women (0.14) as compared to men. Between 19961999 the AAIR for hepatoblastoma was 5.11 in women and 1.85 in men. The age group with the highest rate was women
BMC Cancer | 2005
Juan Manuel Mejía-Aranguré; Miguel Bonilla; Rodolpho Lorenzana; Servando Juárez-Ocaña; Gladys de Reyes; María Luisa Pérez-Saldivar; Guadalupe González-Miranda; Roberto Bernáldez-Ríos; Antonio Ortíz-Fernández; Manuel Carlos Ortega-Alvarez; María del Carmen Martínez-García; Arturo Fajardo-Gutiérrez
Paediatric and Perinatal Epidemiology | 2002
Victor Amozorrutia-Alegria; Juan Carlos Bravo-Ortiz; Josefina Vazquez-Viveros; Laura Campos-Campos; Manuel Mejia-Arangure; Servando Juárez-Ocaña; María del Carmen Martínez-García; Arturo Fajardo-Gutiérrez
Revista médica del Instituto Mexicano del Seguro Social | 2007
Arturo Fajardo-Gutiérrez; Servando Juárez-Ocaña; Guadalupe González-Miranda; Palma-Padilla; Rogelio Carreón-Cruz; Juan Manuel Mejía-Aranguré
Gaceta Medica De Mexico | 2001
Servando Juárez-Ocaña; José Luis Pizaña-Venegas; José Mercedes Farfán-Canto; Felipe de Jesús Espinosa-Acevedo; Arturo Fajardo-Gutiérrez